All News

Through cancer treatment, loss, as well as many life changes, I found healing in simple moments of community and laughter that lifted my spirit.

Watch a webinar as experts on tenosynovial giant cell tumor (TGCT) share an overview of TGCT and a simple summary of the MOTION study.

CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in an interview with CURE.

I share how my friendship with advocate Amy Byer Shainman helped me navigate hereditary cancer, showing that real support comes from empath and honesty.

Personalized vaccines are currently being investigated for the treatment of patients with kidney cancer; however, the investigation is still in early stages.

Study finds anti-nausea drug aprepitant boosts distant disease-free and breast cancer-specific survival in early-stage triple-negative breast cancer.

Through three family cancer diagnoses, and my own life-threatening stage 3b lung cancer verdict, family support and reconnection helped support me.

Dr. Rosario Ligresti discussed common signs and symptoms of GIST, as well as highlighted how the treatment landscape has changed in recent years.

The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung cancer.

Although GIST can be identified during an endoscopy, according to Dr. Rosario Ligresti, these are still rare tumors that warrant further characterization.

CURE spoke with a clinical social worker about issues faced by families dealing with cancer as kids return to school.

Structured resistance training is safe for breast cancer patients, improving arm muscle and reducing lymphedema during and after treatment.

Although gastrointestinal stromal tumor, or GIST, is a rare type of cancer, between 4,000 and 6,000 people are diagnosed with GIST in the U.S. yearly.

When I was diagnosed with breast cancer, I found strength, support, and hope through friendship and community that carried me through the hardest moments.

For patients undergoing a radical cystectomy, staying active before and after surgery is key, Dr. Janet Kukreja explained.

ctDNA-MRD testing better predicted outcomes versus PET/CT scans for large B-cell lymphoma, leading to NCCN guideline updates for remission assessment.

Natural killer cells, also referred to as NK cells, play several major roles in the body's defense against cancers like renal cell carcinoma.

A new AI precision medicine test is being used to help clinicians better identify a personalized treatment plan to treat patients with prostate cancer.

Breast cancer survivors who lost ≤5% of body weight with diet and exercise experienced greater weight loss, improved function, and less pain with Contrave.

Data show that the cancer vaccine Cylembio plus Keytruda demonstrated clinical improvement in progression-free survival in unresectable/advanced melanoma.

A nationwide survey of patients and caregivers has found educational and financial disparities in brain cancer care.

Dena Paluck, whose daughter Laura had osteosarcoma, volunteers with Hopeful Hearts to connect parents of children with cancer to support networks.

It is important to expand clinical trial access for patients with kidney cancer in order to ensure a representative study population.

Intensive chemotherapy improved survival in patients with accelerated and blast phase myeloproliferative neoplasms, with Venclexta showing no clear benefit.

A diagnosis of breast cancer isn’t something most people would think of as a teacher, but sometimes important lessons come to us in unexpected ways.

Cancer treatments can speed up aging in survivors, according to research, which can contribute to a person's risk for conditions like heart disease.

The FDA has granted fast track designation to HLD-0915 for metastatic castration-resistant prostate cancer.

The accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation, is a step in the right direction but more work remains.

Breast cancer survivor and researcher LaShae Rolle studies how individualized strength training during chemo boosts physical, mental and emotional health.

Dr. Jim Omel, who was diagnosed with multiple myeloma in 1997, explained how the treatment landscape has changed over nearly 30 years.